Mar 2017 $2 M No. 7 Under $2 million 1
BI02 Medical, Inc.: Raise no. 7, Mar 2017 × Investors in this round 1 investor had bought by the notice of Mar 31, 2017: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $8 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director Luis Angel · Executive Officer, Director Alan Dean · Director John Creecy · Director John Elwood · Director Paul Castella · Director Steven Bailey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.”Signed by Christopher Banas, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 31, 2017. Read the notice at the SEC .
debt, options SEC Jul 2015 $4 M No. 6 $2 to $10 million 1
BI02 Medical, Inc.: Raise no. 6, Jul 2015 × Investors in this round 1 investor had bought by the notice of Jul 10, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $10 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director Luis Angel · Executive Officer, Director Alan Dean · Director John Creecy · Director John Elwood · Director Paul Castella · Director Steven Bailey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.”Signed by Christopher Banas, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 10, 2015. Read the notice at the SEC .
equity SEC Feb 2014 $6 M No. 5 $2 to $10 million 10
BI02 Medical, Inc.: Raise no. 5, Feb 2014 × Investors in this round 10 investors had bought by the notice of Mar 14, 2014: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $8 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $164,196
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director Luis Angel · Executive Officer, Director Alan Dean · Director John Creecy · Director Paul Castella · Director Steven Bailey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Braymen, Lambert & Noel Securities, Ltd. (CRD 124902) · broker-dealer Braymen, Lambert & Noel Securities, Ltd. (CRD 124902) · San Antonio, Texas Sold in TX Remarks in the notice On the use of proceeds: “A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.”Signed by Christopher Banas, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 14, 2014. Read the notice at the SEC .
equity SEC Aug 2012 $12 M No. 4 $10 to $50 million 30
BI02 Medical, Inc.: Raise no. 4, Aug 2012 × Investors in this round 30 investors had bought by the notice of Sep 5, 2012: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $20 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $349,485
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director Luis Angel · Executive Officer, Director Paul Castella · Executive Officer, Director Alan Dean · Director John Creecy · Director Steven Bailey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Karutz Flavin Wells Investment Bankers, LLC · broker-dealer Braymen, Lambert and Noel Securities, Ltd. (CRD 124902) · San Antonio, Texas Sold in TX Remarks in the notice On the use of proceeds: “A portion of the proceeds will be used to pay the salaries to be paid to the person named in response toItem 3 above”Signed by Paul Castella, President. Source: SEC Form D, newest notice filed Sep 5, 2012. Read the notice at the SEC .
equity SEC Jul 2011 $5 M No. 3 $2 to $10 million 66
BI02 Medical, Inc.: Raise no. 3, Jul 2011 × Investors in this round 66 investors had bought by the notice of Aug 11, 2011: 66 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $191,338
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director, Promoter Luis Angel · Executive Officer, Director, Promoter Paul Castella · Executive Officer, Director, Promoter Alan Dean · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Karutz Flavin Wells Investment Bankers, LLC · broker-dealer Braymen, Lambert and Noel Securities, Ltd. (CRD 124902) · San Antonio, Texas Sold in HI, TX, WA Remarks in the notice On the use of proceeds: “A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above”Signed by Paul Castella, President. Source: SEC Form D, newest notice filed Aug 11, 2011. Read the notice at the SEC .
equity SEC Mar 2010 $7 M No. 2 $2 to $10 million 57
BI02 Medical, Inc.: Raise no. 2, Mar 2010 × Investors in this round 57 investors had bought by the notice of May 4, 2010: 57 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $8 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $273,933
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director, Promoter Luis Angel · Executive Officer, Director, Promoter Paul Castella · Executive Officer, Director, Promoter Alan Dean · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Karutz Flavin Wells Investment Bankers, LLC · broker-dealer BLN Securities Ltd (CRD 124902) · San Antonio, Texas Sold in HI, TX, WA Remarks in the notice On the amounts: “$1,041,983.56 issued upon conversion of the principal and unaccrued unpaid interest under outstanding convertible promissory notes issued by the Issuer”On the use of proceeds: “A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above”Signed by Paul Castella, President. Source: SEC Form D and 1 amendment, newest notice filed May 4, 2010. Read the notice at the SEC .
equity SEC Sep 2009 $1 M No. 1 Under $2 million 8
BI02 Medical, Inc.: Raise no. 1, Sep 2009 × Investors in this round 8 investors had bought by the notice of Apr 13, 2010: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $20,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Christopher Banas · Executive Officer, Director Luis Angel · Executive Officer, Director Paul Castella · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Karutz Flavin Wells Investment Bankers, LLC (CRD 124902) · San Antonio, Texas Sold in TX Remarks in the notice On the use of proceeds: “Does not include amounts to be paid to executive officers of the Issuer in their capacity as employees of the Issuer.”Signed by Paul Castella, President. Source: SEC Form D, newest notice filed Apr 13, 2010. Read the notice at the SEC .
debt, options SEC